Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

OTHER 9INDUSTRY 4OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Plasma cell 1Gastrointestinal 1Breast 1

Conditions

Multiple Myeloma 39Neoplasms, Plasma Cell 8Lymphoma 8Hematologic Neoplasms 5Recurrence 3Leukemia 3Lymphoma, B-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Immunoglobulin Light-chain Amyloidosis 2Disease Progression 2Smoldering Multiple Myeloma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pneumonia, Pneumococcal 1Pneumococcal Infections 1Peripheral Nervous System Diseases 1Neoplasms 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Monoclonal Gammopathy of Undetermined Significance 1Mesothelioma, Malignant 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Plasma Cell 1Hodgkin Disease 1Heart Neoplasms 1Fractures, Spontaneous 1Febrile Neutropenia 1Esophageal Squamous Cell Carcinoma 1Colorectal Neoplasms 1Colonic Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Peripheral Nervous System Diseases × Plasma cell × Clear all
NCT00872352 2009-03-31

Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients

Wolfson Medical Center

Phase 3 Unknown
30 enrolled
Plasma cell

Multiple Myeloma, Peripheral Nervous System Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡